113 related articles for article (PubMed ID: 11083992)
1. [Nebulized prostacyclin treatment for pulmonary hypertension in a 2-year-old girl].
Puigarnau Vallhonrat R; Pons Odena M; Carballo Ruano E
An Esp Pediatr; 2000 Oct; 53(4):372-6. PubMed ID: 11083992
[TBL] [Abstract][Full Text] [Related]
2. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
3. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
4. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ
J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary arterial hypertension treated with prostacyclin or calcium blockers].
Andreassen AK; Geiran O; Madsen S; Hognestad A; Simonsen S
Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3393-6. PubMed ID: 14713978
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
7. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
8. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
Frost AE; Quiñones MA; Zoghbi WA; Noon GP
J Heart Lung Transplant; 2005 Apr; 24(4):501-3. PubMed ID: 15797757
[TBL] [Abstract][Full Text] [Related]
9. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
Kramer MR; Fucks S; Simon Z; Berkman N
Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
[TBL] [Abstract][Full Text] [Related]
10. Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls.
Forrest IA; Small T; Corris PA
Clin Sci (Lond); 1999 Jul; 97(1):99-102. PubMed ID: 10369800
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy].
Uchi M; Saji T; Harada T
J Cardiol; 2005 Nov; 46(5):183-93. PubMed ID: 16320975
[TBL] [Abstract][Full Text] [Related]
12. Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.
Sakai T; Planinsic RM; Mathier MA; de Vera ME; Venkataramanan R
Transpl Int; 2009 May; 22(5):554-61. PubMed ID: 19175541
[TBL] [Abstract][Full Text] [Related]
13. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
14. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
Jerath A; Srinivas C; Vegas A; Brister S
Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
[TBL] [Abstract][Full Text] [Related]
15. Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy.
Schwerzmann M; Zafar M; McLaughlin PR; Chamberlain DW; Webb G; Granton J
Int J Cardiol; 2006 Jun; 110(1):104-7. PubMed ID: 15992947
[TBL] [Abstract][Full Text] [Related]
16. Bosentan: new preparation. Pulmonary hypertension: an option before epoprostenol infusion.
Prescrire Int; 2005 Apr; 14(76):47-50. PubMed ID: 15875338
[TBL] [Abstract][Full Text] [Related]
17. [Prostacyclin oral internal therapy for severe pulmonary hypertension after total correction of cor triatriatum with partial anomalous pulmonary venous return; report of a case].
Hamawaki M; Tomino T; Sato H; Imura M; Suzuki K; Nakashima K; Okamoto Y
Kyobu Geka; 2004 Feb; 57(2):147-50. PubMed ID: 14978912
[TBL] [Abstract][Full Text] [Related]
18. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
[TBL] [Abstract][Full Text] [Related]
19. Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension.
Hirabayashi A; Miyaji K; Akagi T
Catheter Cardiovasc Interv; 2009 Apr; 73(5):688-91. PubMed ID: 19133673
[TBL] [Abstract][Full Text] [Related]
20. [Primary pulmonary hypertension: new treatment options].
Madan S; Boonstra A; Berger RM
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1836-42. PubMed ID: 11593786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
